Finance

Beta
Lists
CMMB:NASDAQ
Chemomab Therapeutics Ltd - ADR
$1.73
-4.41%
(-0.080) 1D
Jun 9, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CMMB...
Open
$1.82
High
$1.85
Low
$1.71
Mkt. cap
12.46M
Avg. vol.
47.85K
Volume
29.04K
52-wk high
$5.40
52-wk low
$1.35
EPS
-$2.16
Beta
0.62
Shares outstanding
7.19M
No. of employees
12
Open
$1.82
High
$1.85
Low
$1.71
Mkt. cap
12.46M
Avg. vol.
47.85K
Volume
29.04K
52-wk high
$5.40
52-wk low
$1.35
EPS
-$2.16
Beta
0.62
Shares outstanding
7.19M
No. of employees
12
Analyst outlook
Analyst Ratings
Based on 2 analysts giving stock ratings to CMMB in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12 month forecast
Based on 2 Wall Street analysts offering 12 month price targets for CMMB in the last 3 months.
Highest
Current $1.73
$25.00 (+1,345.09%)
Average
$15.00 (+767.05%)
Lowest
$5.00 (+189.02%)
News stories
From sources across the web
About Chemomab Therapeutics Ltd - ADR
CEO-
Employees12
Founded2011
Headquarters-
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.29M
960.00K
1.09M
925.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
975.00K
884.00K
881.00K
925.00K
Operating expense
2.26M
1.84M
1.97M
1.85M
Total operating expenses
2.26M
1.84M
1.97M
1.85M
Operating income
-2.26M
-1.84M
-1.97M
-1.85M
Other non operating income
-
-
-
-
EBT including unusual items
-2.06M
-1.74M
-1.87M
-1.77M
EBT excluding unusual items
-2.06M
-1.74M
-1.87M
-1.77M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2.06M
-1.74M
-1.87M
-1.77M
Net profit margin
-
-
-
-
Earnings per share
-0.02
-0.00
-0.00
-0.00
Interest and investment income
205.00K
102.00K
-
77.00K
Interest expense
-
-
-24.00K
-
Net interest expenses
205.00K
102.00K
-24.00K
77.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.25M
-1.83M
-1.96M
-1.83M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more